Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Kefir Peptides Supplement for Inflammation, Oxidative Stress and Lipid Abnormalities in Chronic Kidney Disease Patients

NCT07260292 is registered in ClinicalTrials.gov with National Chung Hsing University as lead sponsor.

NCT NCT07260292
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07260292 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Kefir Peptides Supplement for Inflammation, Oxidative Stress and Lipid Abnormalities in Chronic Kidney Disease Patients
Lead sponsor
National Chung Hsing University
Phase
Not applicable
Overall status
Completed
Start date
February 3, 2023
Completion date
August 2, 2024
Enrollment
165 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease stage 3, chronic kidney disease stage 4, proteinuria